April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Histopathologic Grading of Anaplasia for Retinoblastoma
Author Affiliations & Notes
  • Pia R. Mendoza
    Ophthalmology, Emory University, Atlanta, GA
  • G Baker Hubbard
    Ophthalmology, Emory University, Atlanta, GA
  • Jill R Wells
    Ophthalmology, Emory University, Atlanta, GA
  • Charles S Specht
    Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA
  • Qing Zhang
    Ophthalmology, Emory University, Atlanta, GA
  • Hans E Grossniklaus
    Ophthalmology, Emory University, Atlanta, GA
  • Footnotes
    Commercial Relationships Pia Mendoza, None; G Hubbard, None; Jill Wells, None; Charles Specht, None; Qing Zhang, None; Hans Grossniklaus, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3079. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pia R. Mendoza, G Baker Hubbard, Jill R Wells, Charles S Specht, Qing Zhang, Hans E Grossniklaus; Histopathologic Grading of Anaplasia for Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3079.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

We hypothesize that there are cytologic characteristics of retinoblastoma that may be important for prognostication. Cellular anaplastic change is known to be a significant phenotypic expression of genetic instability and malignant transformation that can be readily recognized under a microscope. The objective of this study is to determine whether the degree of anaplasia correlates with routinely assessed histologic features and clinical outcomes in a series of retinoblastoma patients.

 
Methods
 

This retrospective study involved the review of demographic, clinical, and pathologic findings from 92 patients who underwent primary enucleation for retinoblastoma. Anaplasia was graded as none, mild, moderate, or severe; defined by increasing nuclear size, number of mitoses, nuclear hyperchromatism, pleomorphism and angularity. Pathologic and clinical data were compared using Kaplan-Meier estimates of event free survival and overall survival. The Fisher’s exact test was used to analyze the association between anaplasia grade and other histologic factors.

 
Results
 

The distribution of anaplasia grades was as follows: 15 mild (16%), 53 moderate (58%), and 24 severe (26%). Six tumors had retinoblastoma associated with retinocytoma; all retinocytoma components had no anaplasia. Increasing grade of anaplasia was associated with decreased overall survival (p=0.03). There was no statistically significant correlation between anaplasia and event free survival. Histopathologic factors statistically associated with anaplasia were level of differentiation (p<0.001), optic nerve invasion (p=0.005), and choroidal invasion (p=0.02).

 
Conclusions
 

Anaplasia grading may be a useful adjunct to standard histopathologic criteria in identifying high risk retinoblastoma patients who may need adjuvant therapy.

 
 
Kaplan-Meier curve showing the association of increasing severity of anaplasia grade with decreased overall survival
 
Kaplan-Meier curve showing the association of increasing severity of anaplasia grade with decreased overall survival
 
Keywords: 703 retinoblastoma • 744 tumors • 638 pathology: human  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×